Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.

Martine E D Chamuleau; Yuri Souwer; S Marieke Van Ham; Adri Zevenbergen; Theresia M Westers; Johannes Berkhof; Chris J L M Meijer; Arjan A van de Loosdrecht; Gert J Ossenkoppele

doi:10.1158/0008-5472.CAN-04-1350

Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.

Identifier:nobleid.org/w1/20260515/EB57FD18

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB57FD18.svg?ark=w1%2F20260515%2FEB57FD18)](https://nobleid.org/work/w1/20260515/EB57FD18)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Martine E D Chamuleau

Arjan A van de Loosdrecht

Gert J Ossenkoppele

Claim authorship of this work

Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.

Identifier:nobleid.org/w1/20260515/EB57FD18

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB57FD18.svg?ark=w1%2F20260515%2FEB57FD18)](https://nobleid.org/work/w1/20260515/EB57FD18)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Martine E D Chamuleau

Arjan A van de Loosdrecht

Gert J Ossenkoppele

Claim authorship of this work